Global health issues that transcend geopolitical borders are altering the nature of global health governance. Sovereign nations are more connected than ever and increasingly exposed to trans-border health risks. Traditional global health governance may not account for involvement of multi-level global health actors such as civil-society organizations, private philanthropies and new intergovernmental alliances. In addition, private entities have engaged with governments to form new public–private partnerships to further common global health objectives. As these new partnerships evolve, new approaches to transparent and accountable global health governance are necessary to assure effective, equitable and ethical actions addressing global health challenges.
Full details at the Journal of Commercial Biotechnology